BRUSSELS - Washington has told the European Union that it should not expect to receive AstraZeneca COVID-19 vaccines manufactured in the United States any time soon, two EU sources said on Thursday, in a new blow to the bloc’s supplies.
AstraZeneca told the EU earlier this year it would cut its supplies in the second quarter by at least half to less than 90 million doses, EU sources told Reuters, after a bigger reduction in the first three months of the year. The move comes after Austria stopped using a batch of AstraZeneca shots while investigating a death from coagulation disorders and an illness from a pulmonary embolism.
The U.S. stance could jeopardise AstraZeneca’s attempts to bring deliveries closer to its contractual obligation with the EU of 180 million doses in the second quarter. The EU drugs regulators are currently reviewing Serum’s manufacturing site, Reuters exclusively reported earlier in March.
Canada got the same answer and treatment. In the last five years the US has gone out if its way to burn a lot of bridges with its allies.
I'm glad to hear that.
It is known that the representatives of pharmaceutical companies, when they want to sell their articles, go to general practitioners, proposing a percentage in case they prescribe them to some patients. But you need to read the package leaflet carefully
Noted
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.